v3.25.3
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Total revenues $ 3,334,106 $ 2,601,229 $ 9,359,933 $ 7,325,249
Cost of goods 2,721,314 2,077,121 7,605,931 5,815,981
Cost of services 220,784 201,016 648,773 581,509
Gross profit 392,008 323,092 1,105,229 927,759
Selling, general, and administrative expenses 304,165 293,995 918,090 875,344
Operating income 87,843 29,097 187,139 52,415
Loss on extinguishment of debt       12,726
Interest expense, net 38,235 46,614 118,776 144,366
Income (loss) from continuing operations before income taxes 49,608 (17,517) 68,363 (104,677)
Income tax expense (benefit) 12,120 8,155 13,118 (31,464)
Income (loss) from continuing operations, net of income taxes 37,488 (25,672) 55,245 (73,213)
Income from discontinued operations, net of income taxes 17,753 16,691 56,548 37,288
Net income (loss) 55,241 (8,981) 111,793 (35,925)
Net loss attributable to noncontrolling interests included in continuing operations (595) (751) (1,793) (1,864)
Net loss attributable to BrightSpring Health Services, Inc. and subsidiaries $ 55,836 $ (8,230) $ 113,586 $ (34,061)
Basic income (loss) per share attributable to common shareholders:        
Continuing operations $ 0.19 $ (0.13) $ 0.28 $ (0.37)
Discontinued operations 0.08 0.09 0.28 0.19
Net income (loss) 0.27 (0.04) 0.56 (0.18)
Diluted income (loss) per share attributable to common shareholders:        
Continuing operations 0.17 (0.13) 0.26 (0.37)
Discontinued operations 0.09 0.09 0.26 0.19
Net income (loss) $ 0.26 $ (0.04) $ 0.52 $ (0.18)
Weighted average shares outstanding:        
Basic 203,487 198,491 202,067 190,541
Diluted 217,982 198,491 218,519 190,541
Products        
Total revenues $ 2,966,966 $ 2,265,697 $ 8,289,238 $ 6,357,223
Services        
Total revenues $ 367,140 $ 335,532 $ 1,070,695 $ 968,026